Cargando…
Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against Mycobacterium tuberculosis H37Rv strain
INTRODUCTION: Tuberculosis (TB) is the single largest infectious disease which requires a prolonged treatment regime with multiple drugs. The present treatment for TB includes frequent administration of a combination of four drugs for a duration of 6 months. This leads to patient’s noncompliance, in...
Autores principales: | Hakkimane, Sushruta S, Shenoy, Vishnu Prasad, Gaonkar, Santosh L, Bairy, Indira, Guru, Bharath Raja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061404/ https://www.ncbi.nlm.nih.gov/pubmed/30087562 http://dx.doi.org/10.2147/IJN.S163925 |
Ejemplares similares
-
In vitro modeling of isoniazid resistance mechanisms in Mycobacterium tuberculosis H37Rv
por: Dokrungkoon, Thanadon, et al.
Publicado: (2023) -
In Silico Identification of Novel Derivatives of Rifampicin Targeting Ribonuclease VapC2 of M. tuberculosis H37Rv: Rifampicin Derivatives Target VapC2 of Mtb H37Rv
por: Maurya, Satyamvada, et al.
Publicado: (2023) -
Evaluation of antimycobacterial activity of Curcuma xanthorrhiza ethanolic extract against Mycobacterium tuberculosis H37Rv in vitro
por: Ngadino,, et al.
Publicado: (2018) -
Fatal poisoning by isoniazid and rifampicin
por: Sridhar, A., et al.
Publicado: (2012) -
Isoniazid- and rifampicin-induced thrombocytopenia
por: Yakar, Fatih, et al.
Publicado: (2013)